NervGen Pharma Corp
NASDAQ:NGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NervGen Pharma Corp
NASDAQ:NGEN
|
CA |
|
Galliford Try Holdings PLC
F:3WC
|
UK |
|
F
|
Friwo AG
SWB:CEA
|
DE |
|
N
|
Nevada Exploration Inc
OTC:NVDEF
|
CA |
|
I
|
INEO Tech Corp
F:0OQ1
|
CA |
|
Turkiye Sinai Kalkinma Bankasi AS
OTC:TRKYY
|
TR |
|
C
|
Charbone Hydrogen Corp
OTC:CHHYF
|
CA |
|
A
|
Alvopetro Energy Ltd
OTC:ALVOF
|
CA |
|
V
|
Volution Group PLC
F:VO1
|
UK |
|
Vineet Laboratories Ltd
BSE:543298
|
IN |
|
Blue Lagoon Resources Inc
OTC:BLAGF
|
CA |
|
L
|
Linius Technologies Ltd
OTC:LNNTF
|
AU |
|
Hillcrest Energy Technologies Ltd
OTC:HLRTF
|
CA |
|
Sanderson Design Group PLC
F:5H7
|
UK |
|
eDreams Odigeo SA
OTC:EDDRF
|
LU |
|
O
|
Omron Corp
XBER:OMR1
|
JP |
|
Japan Cash Machine Co Ltd
F:JCM
|
JP |
|
Birks Group Inc
F:2BG
|
CA |
|
Morgan Advanced Materials PLC
F:MGJ
|
UK |
Bankruptcy Probability
NervGen Pharma Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NervGen Pharma Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
NervGen Pharma Corp
XTSX:NGEN
|
234.7m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
366.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
212.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
180.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
266.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NervGen Pharma Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NervGen Pharma Corp has no debt.
You can find a full breakdown on its Balance Sheet.
